As the Assistant Director of Program Evaluation at the BU CTSI, Kayla J. Kuhfeldt, MPH leads the CTSI evaluation team in their continuous quality improvement processes and evaluation plans and activities. Her expertise is in community assessment, program design, implementation, and evaluation, applied research methodology, and participatory evaluation approaches. She is experienced in working with global stakeholders to help evaluate programs, identify gaps, and find ways to improve systems and policies. She is certified in Lean Methods and Six Sigma used in continuous quality improvement processes. Kayla is beginning her term as the program chair of the Translational Research Evaluation topical interest group of the American Evaluation Association in 2023, which is comprised of association members who are focused on advancing methods and models for evaluating the progress of research through the translational research process in their pursuit of evaluation best practices.
Kayla also serves as a mentor for multiple graduate students in the Boston University School of Public Health's Alumni Mentorship Program to provide career and professional development to BUSPH alumni and graduate students. She is dedicated to help foster professional growth for current and future public health practitioners.
Kayla received a Master of Public Health from Boston University School of Public Health with a Community Assessment, Program Design, Implementation, and Evaluation Functional Certificate and a Global Health Context Certificate. She completed her Bachelor of Science in Biology and Bachelor of Arts in Health, Society, and Populations from the University of Kentucky. Kayla's current interests include infectious diseases, reducing global disease burdens, HIV/AIDS program planning, implementation and evaluation, along with improving systems that perpetuate inequity and inequalities in healthcare systems globally.
Diversity, Equity, Inclusion and Accessibility
I am committed to make diversity, equity, inclusion, and accessibility (DEIA) a part of and at the forefront of everything I do as a program evaluator. I strive to use evaluation practices that ensure that stakeholders impacted by an evaluation have a voice and are all at the table. All stakeholders should feel their role and input is important and necessary. Being attentive to engaging diverse and inclusive stakeholder groups in evaluation activities will lead to meaningful and accurate results that could encourage policy and program changes that are equitable. Also, I emphasize evaluating efforts to promote cultural inclusion and making recommendations for needed adjustments that will help to create a culturally inclusive environment and enhance cultural competence within programs.
As a public health professional, I am dedicated to improving systems that perpetuate inequity and inequalities in healthcare systems globally. I undertake approaches to creating solutions and systems that also are committed to DEIA principles. This is essential because a social justice lens to population health recognizes that the underlying concerns of racism, socioeconomic inequality, gender discrimination, and hate have negative health consequences.
Some of my DEIA focused activities, awards, and research include the following:
• 2019-2020 Policy & Advocacy Intern, South Africa Development Fund, Cape Town, South Africa
• 2019 Community Health Intern, Yantaló Peru Foundation, Yantaló, Peru
• 2018 Overdose Prevention & Bystander Training, Boston Public Health Commission, Boston, MA
• 2016-2018 Student Ambassador, Officer, & Mentor, I am a Woman in STEM, University of Kentucky, Lexington, KY
• 2017 & 2018 Women & Philanthropy’s Scholarship, University of Kentucky, Lexington, KY
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Turcinovic J, Kuhfeldt K, Sullivan M, Landaverde L, Platt JT, Doucette-Stamm L, Hanage WP, Hamer DH, Klapperich C, Landsberg HE, Connor JH. Linking contact tracing with genomic surveillance to deconvolute SARS-CoV-2 transmission on a university campus. iScience. 2022 Nov 18; 25(11):105337.View Related Profiles. PMID: 36246573; PMCID: PMC9554197; DOI: 10.1016/j.isci.2022.105337;
Kuhfeldt K, Turcinovic J, Sullivan M, Landaverde L, Doucette-Stamm L, Hamer DH, Platt JT, Klapperich C, Landsberg HE, Connor JH. Examination of SARS-CoV-2 In-Class Transmission at a Large Urban University With Public Health Mandates Using Epidemiological and Genomic Methodology. JAMA Netw Open. 2022 Aug 01; 5(8):e2225430.View Related Profiles. PMID: 35930286; PMCID: PMC9356317; DOI: 10.1001/jamanetworkopen.2022.25430;
Fong RM, Kaiser JL, Ngoma T, Vian T, Bwalya M, Sakanga VR, Lori JR, Kuhfeldt KJ, Musonda G, Munro-Kramer M, Rockers PC, Hamer DH, Ahmed Mdluli E, Biemba G, Scott NA. Barriers and facilitators to facility-based delivery in rural Zambia: a qualitative study of women's perceptions after implementation of an improved maternity waiting homes intervention. BMJ Open. 2022 Jul 25; 12(7):e058512.View Related Profiles. PMID: 35879007; PMCID: PMC9328096; DOI: 10.1136/bmjopen-2021-058512;
Kuhfeldt K, Turcinovic J, Sullivan M, Landaverde L, Doucette-Stamm L, Hamer DH, Platt J, Klapperich C, Landsberg HE, Connor JH. Minimal SARS-CoV-2 classroom transmission at a large urban university experiencing repeated into campus introduction. medRxiv. 2022 Mar 16.View Related Profiles. PMID: 35313596; PMCID: PMC8936094; DOI: 10.1101/2022.03.16.22271983;
Davidi D, Fitzgerald S, Glaspell HL, Jalbert S, Klapperich CM, Landaverde L, Maheras S, Mattoon SE, Britto VM, Nguyen GT, Platt JT, Kuhfeldt K, Landsberg H, Stuopis CW, Turse JE, Hamer DH, Springer M. Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests. Cell Rep Methods. 2021 May 24; 1(1):100005.View Related Profiles. PMID: 34235497; PMCID: PMC8017732; DOI: 10.1016/j.crmeth.2021.100005;
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.